The latest closing stock price for Karyopharm Therapeutics as of September 18, 2024 is 0.74.
An investor who bought $1,000 worth of Karyopharm Therapeutics stock at the IPO in 2013 would have $-954 today, roughly -1 times their original investment - a -24.43% compound annual growth rate over 11 years.
The all-time high Karyopharm Therapeutics stock closing price was 47.12 on June 13, 2014.
The Karyopharm Therapeutics 52-week high stock price is 1.95, which is 163.5% above the current share price.
The Karyopharm Therapeutics 52-week low stock price is 0.62, which is 16.2% below the current share price.
The average Karyopharm Therapeutics stock price for the last 52 weeks is 1.01.
An investor who bought $1,000 worth of Karyopharm Therapeutics stock at the IPO in 2013 would have $-954 today, roughly -1 times their original investment - a -24.43% compound annual growth rate over 11 years.
The all-time high Karyopharm Therapeutics stock closing price was 47.12 on June 13, 2014.
The Karyopharm Therapeutics 52-week high stock price is 1.95, which is 163.5% above the current share price.
The Karyopharm Therapeutics 52-week low stock price is 0.62, which is 16.2% below the current share price.
The average Karyopharm Therapeutics stock price for the last 52 weeks is 1.01.